These results suggest that there is a correlation between CXXC5 and ESR1 expressions in ER+ breast cancer and that a deregulated expression of CXXC5 could contribute to the initiation and/or progression of ERα+ breast cancer. Here, ESR1 is linked to breast carcinoma.